WO2002009672A1 - Liposome gelatineux compose, sa composition et ses applications - Google Patents

Liposome gelatineux compose, sa composition et ses applications Download PDF

Info

Publication number
WO2002009672A1
WO2002009672A1 PCT/CN2001/001152 CN0101152W WO0209672A1 WO 2002009672 A1 WO2002009672 A1 WO 2002009672A1 CN 0101152 W CN0101152 W CN 0101152W WO 0209672 A1 WO0209672 A1 WO 0209672A1
Authority
WO
WIPO (PCT)
Prior art keywords
liposomes
internal phase
liposomes containing
gelled aqueous
aqueous internal
Prior art date
Application number
PCT/CN2001/001152
Other languages
English (en)
Chinese (zh)
Inventor
Qun Zeng
Original Assignee
Qun Zeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qun Zeng filed Critical Qun Zeng
Priority to AU2002212059A priority Critical patent/AU2002212059A1/en
Publication of WO2002009672A1 publication Critical patent/WO2002009672A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un liposome gélatineux composé, sa composition et ses applications dans le domaine des substances bioactives stables. La phase interne du liposome gélatineux se présente sous forme d'hydrogel. Les avantages qui en découlent sont une bonne étanchéité en raison de son enveloppe, une meilleure agrégation de son corps, une bonne précipitation et une bonne stabilité chimique ainsi qu'une faible peroxydation phospholipidique. Par ailleurs, la stabilité de la substance bioactive s'en trouve améliorée et sa libération est retardée. Aussi, outre les applications semblables à celles des liposomes non gélatineux, le liposome gélatineux faisant l'objet de cette invention tient lieu de stabilisant de substances bioactives.
PCT/CN2001/001152 2000-07-12 2001-07-03 Liposome gelatineux compose, sa composition et ses applications WO2002009672A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002212059A AU2002212059A1 (en) 2000-07-12 2001-07-03 Liposomes containing a gelled aqueous internal phase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00120726.1 2000-07-12
CNB001207261A CN1136841C (zh) 2000-07-12 2000-07-12 组凝胶型脂质体及其组合物与应用

Publications (1)

Publication Number Publication Date
WO2002009672A1 true WO2002009672A1 (fr) 2002-02-07

Family

ID=4588357

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/001152 WO2002009672A1 (fr) 2000-07-12 2001-07-03 Liposome gelatineux compose, sa composition et ses applications

Country Status (3)

Country Link
CN (1) CN1136841C (fr)
AU (1) AU2002212059A1 (fr)
WO (1) WO2002009672A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062299A1 (fr) * 2007-11-15 2009-05-22 Lipodur Pharmaceutical Inc. Compositions de liposomes stabilisés par un gel, leurs procédés de préparation et leurs utilisations
US8846126B2 (en) 2008-11-14 2014-09-30 Archer Daniels Midland Company Food compositions comprising organogels

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009313928B2 (en) * 2008-11-14 2015-07-09 Archer Daniels Midland Company Organogel compositions and processes for producing
CN103656746A (zh) * 2013-12-13 2014-03-26 无锡合众信息科技有限公司 一种可自愈水凝胶玻璃体填充物及其制备方法
CN106214642A (zh) * 2016-08-30 2016-12-14 铜陵翔宇商贸有限公司 豆磷脂脂质体及其制备方法
CN112043632A (zh) * 2020-08-19 2020-12-08 上海中翊日化有限公司 一种葡萄籽提取物双包裹体的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002267A1 (fr) * 1987-09-15 1989-03-23 Inst Nat Sante Rech Med Liposomes, leur procede et application comme vecteur de produits

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002267A1 (fr) * 1987-09-15 1989-03-23 Inst Nat Sante Rech Med Liposomes, leur procede et application comme vecteur de produits

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.C. HAURON ET AL.: "A new type of liposome for electrochemical treatment of cancer: the lipogelesomes", EUR. J. SERG., no. SUPPL. 574, 1994, pages 117 - 119 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062299A1 (fr) * 2007-11-15 2009-05-22 Lipodur Pharmaceutical Inc. Compositions de liposomes stabilisés par un gel, leurs procédés de préparation et leurs utilisations
US8846126B2 (en) 2008-11-14 2014-09-30 Archer Daniels Midland Company Food compositions comprising organogels

Also Published As

Publication number Publication date
CN1280824A (zh) 2001-01-24
CN1136841C (zh) 2004-02-04
AU2002212059A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
WO1999063826A3 (fr) Agents pour lutter contre des parasites de vegetaux
WO2000029404A8 (fr) Derives de pyrimidinylbenzimidazole et de triazinylbenzimidazole et bactericides agricoles/horticoles
CA2333528A1 (fr) Sirop a antihistamines stabilise contenant un stabilisant acide aminopolycarboxylique
WO2001095856A3 (fr) Derive d'uree en tant qu'agent anticancereux et son procede de preparation
CA2382098A1 (fr) Formes de presentation pharmaceutiques orales a action retardee
AU2002226674A1 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
EP1386606A4 (fr) Produit d'injection stable a des concentrations elevees contenant un derive de pyrazolone
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
WO2001007049A3 (fr) Composition ophthalmique
AU6440600A (en) Combination of active agents, said combination containing clonidine
AU2001272383A1 (en) Fungicidal combinations of active agents
WO2001093816A3 (fr) Compositions stabilisees renfermant des principes actifs qui sont labiles en presence d'oxygene
AU3240301A (en) A stable composition comprising epidermal growth factor as an active ingredient
WO2003020200A3 (fr) Nouveau compose pharmaceutique et procedes de fabrication et d'utilisation de ce compose
WO2002009672A1 (fr) Liposome gelatineux compose, sa composition et ses applications
WO2004017943A3 (fr) Formulations lipidiques cationiques non vesiculaires
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
WO2000046210A3 (fr) Nouveau procede de preparation d'intermediaires pesticides
EP1550667A4 (fr) Agents de regulation de l'activite de la tyrosinase, procede de production desdits agents et preparations externes contenant lesdits agents
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
EP1059090A4 (fr) Medicaments contre l'infarcissement du cerveau
EP1008345A4 (fr) Agents anti-allergiques
WO2002060405A8 (fr) Composition dermatologique veterinaire contenant une base sphingoide et/ou un derive de base sphingoide
CA2349452A1 (fr) Medicaments contre la dependance aux drogues

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP